Bacterial DNA does not increase serum corticosterone concentration or prevent increases induced by other stimuli.
Bacterial DNA containing unmethylated CpG motifs (CpG DNA) and other microbial molecules such as lipopolysaccharide (LPS) have a broad range of immune stimulatory effects, which may include many shared cell signaling pathways leading to enhanced cytokine production. Some cytokines activate the hypothalamic-pituitary-adrenal (HPA) axis, and their production is downregulated by products of the HPA axis (glucocorticoids). Because such interactions have practical implications in the clinical use of CpG DNA, the present study was done to examine the effects of CpG DNA and LPS on serum corticosterone concentrations. In contrast to LPS, administration of CpG DNA (DNA from Escherichia coli) (30-300 microg) alone did not significantly increase serum corticosterone concentrations 1 or 4 h after administration. Administration of CpG DNA to mice prior to LPS caused a synergistic increase in serum tumor necrosis factor-alpha (TNF-alpha), indicative of an immune stimulatory effect. LPS and TNF-alpha, however, induced similar levels of corticosterone with or without concomitant CpG DNA. Increasing doses of LPS caused peak corticosterone levels similar to those induced by LPS in combination with CpG DNA. Exogenous TNF-alpha administered in vivo induced comparable concentrations of corticosterone with or without CpG DNA. An alternative stressor (restraint) yielded similar levels of corticosterone with or without CpG DNA. These results indicate that CpG DNA does not induce corticosterone release or alter its release by other stimuli, indicating biologically important differences in its immune effect compared to those of LPS, and possibly reduced toxicity.
Myers
L P
LP
Department of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport 71130, USA.
Krieg
A M
AM
Pruett
S B
SB
D000818:Animals; D002417:Cattle; D003345:Corticosterone / Q000096:biosynthesis / Q000097:blood*; D004269:DNA, Bacterial / Q000008:administration & dosage* / Q000494:pharmacology; D004306:Dose-Response Relationship, Immunologic; D004926:Escherichia coli / Q000276:immunology; D005260:Female; D007275:Injections, Intravenous; D018664:Interleukin-12 / Q000096:biosynthesis / Q000097:blood; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D012149:Restraint, Physical; D013312:Stress, Physiological / Q000276:immunology; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism / Q000494:pharmacology
D004269:DNA, Bacterial; D014409:Tumor Necrosis Factor-alpha; D018664:Interleukin-12; D003345:Corticosterone